Endocrinology

GLP-1 Medication Consultation in Seomyeon, Busan

A GLP-1 medication consultation assesses whether a GLP-1 receptor agonist, such as semaglutide, or a dual GIP/GLP-1 agonist such as tirzepatide, is appropriate for type 2 diabetes or weight management. In Seomyeon, endocrinology clinics review your medical history, weight, blood tests and contraindications, then explain dosing, usually a weekly injection started low and increased gradually, with follow-up every few weeks to manage side effects.

Independent patient guide · Medically informative, not a substitute for a doctor's advice · Last reviewed:

October 2026
Clinic in Seomyeon, Busan

What is GLP-1 therapy?

GLP-1 receptor agonists mimic a gut hormone that increases insulin release when blood sugar is high, slows stomach emptying and reduces appetite through the brain. Originally developed for type 2 diabetes, several are now approved for weight management, where they produce substantially greater weight loss than older medicines when combined with diet and activity. Tirzepatide also acts on the GIP receptor. Some GLP-1 drugs have shown cardiovascular benefits in people with established heart disease.

Who is it for?

  • Adults with type 2 diabetes, especially with heart disease, kidney disease or obesity
  • Adults with obesity, or overweight with weight-related conditions such as high blood pressure, prediabetes or sleep apnea, according to approved criteria
  • People who have not achieved goals with lifestyle change alone

These medicines are not suitable during pregnancy or breastfeeding, and are generally avoided with a personal or family history of medullary thyroid cancer or MEN2, and used cautiously after pancreatitis. Severe persistent abdominal pain, especially spreading to the back, needs urgent care.

What happens at the clinic

  1. Assessment: weight, BMI, waist, blood pressure, medical history, medicines and previous weight-loss attempts.
  2. Blood tests: HbA1c, kidney and liver function, lipids and sometimes thyroid tests.
  3. Discussion: realistic expectations, side effects, cost and the need for ongoing lifestyle support.
  4. Injection teaching: how to use the pen, rotate sites and store the medicine.
  5. Titration and follow-up: the dose increases gradually every few weeks; visits review side effects, weight, nutrition and muscle preservation.

Treatment outlook

Many people lose a meaningful amount of weight over 6–12 months, and blood sugar typically improves. Eating protein, staying active with resistance exercise, and drinking enough water help preserve muscle and reduce side effects. Weight often returns when medicine is stopped, so long-term planning is important.

Risks and side effects

Nausea, vomiting, fullness, constipation and diarrhea are common, especially during dose increases. Less common risks include gallstones, pancreatitis and dehydration-related kidney problems. When combined with insulin or sulfonylureas, low blood sugar can occur. Counterfeit or compounded products sold online are a safety risk; use only medicines prescribed by a doctor and dispensed by a pharmacy.

Choosing a clinic for GLP-1 therapy in Seomyeon

  • Choose a physician who performs a full medical assessment, not a quick prescription.
  • Ask about follow-up frequency and how side effects will be managed.
  • Ask whether nutrition and exercise support are included.
  • Confirm the medicine is dispensed through a licensed pharmacy.
  • Discuss a long-term plan, including what happens if you stop.

Regular reviews

Dose increases need regular check-ins. Clinics near Seomyeon Station, on Busan Metro Lines 1 and 2, make these visits easy to schedule.

Key facts

  • Used for: type 2 diabetes; chronic weight management in eligible adults
  • Examples: semaglutide, liraglutide, tirzepatide (dual GIP/GLP-1)
  • Dosing: mostly weekly injections, titrated over weeks to months
  • Common side effects: nausea, fullness, constipation or diarrhea
  • Screening: history of pancreatitis, gallbladder disease, medullary thyroid cancer, pregnancy plans
  • Typical NHI coverage: weight-loss use is generally not covered; diabetes use depends on criteria

Frequently asked questions

How much weight can I lose with GLP-1 medicines?

Results vary, but many people lose a meaningful percentage of body weight over 6 to 12 months alongside diet and activity changes. Your doctor can discuss realistic expectations for your situation.

What are the common side effects of GLP-1 drugs?

Nausea, vomiting, feeling full, constipation and diarrhea are common, especially when increasing the dose. Eating smaller meals and avoiding fatty food often helps.

Who should not take GLP-1 medicines?

People who are pregnant or breastfeeding, those with a personal or family history of medullary thyroid cancer or MEN2, and people with certain pancreatic or gallbladder conditions may need to avoid them. Your doctor will screen you.

Will I regain weight if I stop?

Many people regain some weight after stopping. Building lasting eating and activity habits, and discussing a long-term plan with your doctor, helps maintain results.

Is GLP-1 therapy covered by insurance in Korea?

Use for weight management is generally paid out of pocket. Coverage for type 2 diabetes depends on specific criteria. Ask the clinic for details before starting.

Medical disclaimer: Seomyeon.Clinic is an independent information directory. Content is for general education and does not replace a consultation with a licensed physician. Suitability, risks, results and costs vary by person and clinic. In an emergency in Korea, call 119.